Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension.
Langleben D, Christman BW, Barst RJ, Dias VC, Galiè N, Higenbottam TW, Kneussl M, Korducki L, Naeije R, Riedel A, Simonneau G, Hirsch AM, Rich S, Robbins IM, Oudiz R, McGoon MD, Badesch DB, Levy RD, Mehta S, Seeger W, Solèr M.
Langleben D, et al. Among authors: kneussl m.
Am Heart J. 2002 May;143(5):E4. doi: 10.1067/mhj.2002.121806.
Am Heart J. 2002.
PMID: 12040360
Clinical Trial.